From chemistry-request@www.ccl.net  Fri Sep 18 07:39:37 1998
Received: from goliat.eik.bme.hu (root@[152.66.250.2])
        by www.ccl.net (8.8.3/8.8.6/OSC/CCL 1.0) with ESMTP id HAA26226
        Fri, 18 Sep 1998 07:39:32 -0400 (EDT)
Received: from localhost (dino@localhost [127.0.0.1])
	by goliat.eik.bme.hu (8.9.1/8.9.1) with SMTP id NAA22544
	for <chemistry@www.ccl.net>; Fri, 18 Sep 1998 13:38:42 +0200 (MET DST)
Date: Fri, 18 Sep 1998 13:38:41 +0200 (MET DST)
From: SZIEBERTH Denes <dino@eik.bme.hu>
To: chemistry@www.ccl.net
Subject: software RAID 0 with g94
Message-ID: <Pine.GSO.4.02A.9809181329120.20336-100000@goliat.eik.bme.hu>



   Hi everyone,

 Has anyone got some experience with software RAID 0 under linux? I would
be interested in performance benchmarks compared to hardware RAID
controllers, preferably IO heavy Gaussian 94 or other QC package run
times...
 I'd really appreciate if someone could give some help...

             Denes Szieberth
             dino@goliat.eik.bme.hu





From chemistry-request@www.ccl.net  Tue Sep 22 08:55:12 1998
Received: from apsu02.apsu.edu (apsu02.apsu.edu [198.146.56.10])
        by www.ccl.net (8.8.3/8.8.6/OSC/CCL 1.0) with ESMTP id IAA17677
        Tue, 22 Sep 1998 08:55:12 -0400 (EDT)
Received: from gostowskir.apsu.edu by APSU02.APSU.EDU (PMDF V5.1-4 #16785)
 with ESMTP id <01J23LK81NYO001RFI@APSU02.APSU.EDU> for
 chemistry@www.ccl.net; Tue, 22 Sep 1998 07:51:55 CST
Date: Tue, 22 Sep 1998 07:57:43 -0500
From: Rudy Gostowski <gostowskir@apsu01.apsu.edu>
Subject: mopac internal coordinates with gamess
To: CCL LIST <chemistry@www.ccl.net>
Message-id: <01J23LK82AGY001RFI@APSU02.APSU.EDU>
MIME-version: 1.0
X-Mailer: Microsoft Internet Mail 4.70.1161
Content-type: text/plain; charset=ISO-8859-1
Content-transfer-encoding: 7bit
X-Priority: 3
X-MSMail-Priority: Normal



I would like to use MOPAC internal coordinates as data for GAMESS.   If you
have an example of this please forward your input file to me.
thanks,

Rudy Gostowski
Department of Chemistry
Austin Peay State University
Box 4547
Clarksville, TN  37044
931-648-7624
FAX 931-648-5996
gostowskir@apsu01.apsu.edu


From chemistry-request@www.ccl.net  Tue Sep 22 10:41:17 1998
Received: from dirac.cnrs-orleans.fr (dirac.cnrs-orleans.fr [163.9.6.67])
        by www.ccl.net (8.8.3/8.8.6/OSC/CCL 1.0) with ESMTP id KAA18930
        Tue, 22 Sep 1998 10:41:16 -0400 (EDT)
Received: (from hinsen@localhost) by dirac.cnrs-orleans.fr (AIX4.3/UCB 8.8.8/8.7) id QAA16812; Tue, 22 Sep 1998 16:38:41 +0200
Date: Tue, 22 Sep 1998 16:38:41 +0200
Message-Id: <199809221438.QAA16812@dirac.cnrs-orleans.fr>
X-Authentication-Warning: dirac.cnrs-orleans.fr: hinsen set sender to hinsen@cnrs-orleans.fr using -f
From: Konrad Hinsen <hinsen@cnrs-orleans.fr>
To: berriz@chasma.harvard.edu
CC: chemistry@www.ccl.net
In-reply-to: <199809201752.NAA28473@potato.harvard.edu> (message from Gabriel
	Berriz on Sun, 20 Sep 1998 13:52:43 -0400)
Subject: Re: CCL:CASP vs. The Tower of Babel
References:  <199809201752.NAA28473@potato.harvard.edu>



> *Nothing* like this happens in my current field.  I'm not sure why,
> but I have a few guesses.  For one thing, programs are a pain to port
> across systems (portability of code is not a criterion for

I haven't yet met a program with serious portability problems; most
people use their own programs on more than one machine, so portability
is important even for the original author himself.

> publication).  More important, in most cases I don't want the program
> just to use as a black box.  On the contrary, my interest in the
> program is usually in how it implements a model; I want not only to
> reproduce published results, but also to tweak the conditions, and to
> extend the experiments.  This invariably requires that I understand

That's a real problem. Writing readable and modifiable code is
difficult, and requires substantial experience in software
development. Few scientists have this experience, or are willing to
acquire it. There is also no external incentive; programs do not
figure on a publication list, much less with an indication of their
quality.

A typical argument for keeping the status quo is "scientists have to
learn so much already, there is no time to learn software development
as well." Considering that software development in computational
chemistry is the equivalent of experimental techniques for the lab
scientist, this is a strange point of view. Would any experimentalist
be taken seriously if he publicly refused to learn the fundamentals of
his techniques? I doubt it.

> 5 years ago half a world away.  (Again, clarity of code is, for the
> most part, not a criterion for publication).  So, typically I conclude

Indeed. One solution might be program publishing in a similar way to
paper publishing: programs would be submitted to publishers who let
external referees judge the quality, including modifiability, before
accepting the code for a collection of "trusted code". However, where
would these referees suddenly come from?

> that either I re-implement the idea from scratch, which is usually
> something I can't afford, or else I drop the matter altogether.

I'd like to know how many potentially good ideas were never tried
because of this barrier!

Working in method development myself, I encountered exactly the same
problems, and finally I decided that starting from scratch was the
only option. Of course I was determined to do it only once, and
moreover to do it right (perhaps I am an optimist). The result of this
effort is the Molecular Modeling Toolkit, available at
http://starship.skyport.net/crew/hinsen/mmtk.html (for anyone, you
don't even have to ask!). A few projects later, I can conclude that it
was well worth the effort; I can implement new ideas very rapidly. It
may not be as transparent for someone else, since the developers'
guide is mostly yet-to-be-written, but that will change some day, once
I manage to get a real job ;-)

The essential feature of this toolkit is a library approach: there is
not a "program" (read: black box), but a set of largely independent
modules implementing specific techniques. For modifying or extending a
particular feature or technique, there is no need to understand the
rest. Most new techniques (e.g. new force fields or new integrators)
can in fact be implemented without ever modifying an existing program
file.
-- 
-------------------------------------------------------------------------------
Konrad Hinsen                            | E-Mail: hinsen@cnrs-orleans.fr
Centre de Biophysique Moleculaire (CNRS) | Tel.: +33-2.38.25.55.69
Rue Charles Sadron                       | Fax:  +33-2.38.63.15.17
45071 Orleans Cedex 2                    | Deutsch/Esperanto/English/
France                                   | Nederlands/Francais
-------------------------------------------------------------------------------


From chemistry-request@www.ccl.net  Tue Sep 22 11:22:41 1998
Received: from piimsdm9.univ-mrs.fr (piimsdm9.univ-mrs.fr [194.57.196.103])
        by www.ccl.net (8.8.3/8.8.6/OSC/CCL 1.0) with SMTP id LAA19653
        Tue, 22 Sep 1998 11:22:40 -0400 (EDT)
From: olivier@piimsdm9.univ-mrs.fr
Received: by piimsdm9.univ-mrs.fr (920330.SGI/920502.SGI)
	for chemistry@www.ccl.net id AA21947; Tue, 22 Sep 98 17:36:16 -0700
Date: Tue, 22 Sep 98 17:36:16 -0700
Message-Id: <9809230036.AA21947@piimsdm9.univ-mrs.fr>
To: chemistry@www.ccl.net
Subject: AIM kw in G94



Hello,
  i want to perform a bond order analysis using the 
AIM=BO keyword in g94. i got the following message in the .log
-------------------------
 II-1. RING POINTS

 ------------------------X----------Y----------Z-------------------------------- ------------------------------------------------------------------------------- Ring                     Cartesian Coordinates          Attractors

 Irreparable ring damage: the gap cannot be bridged in a unique way
 Error termination via Lnk1e in /usr/oem/g94/l609.exe.



-------------------------
 Can anyone help me to solve my problem?

Thanks.



        PPPPPPPP    II     II   MM     MM 
        PP      P   II     II   MMM   MMM 
        PPPPPPPP    II     II   MM M M MM 
 _____  PP          II     II   MM  M  MM  
|       PP          Ii     II   MM     MM 
|                                        
| MARESCA Olivier                         |
| PIIM - CNRS UMR 6633                    |
| Spectrometrie et Dynamique Moleculaire  |
| Campus Universitaire Saint Jerome       |
| Service 542                             |
| 13397 Marseille Cedex 20 - France       |
|                                         |  
| Tel : +33  4.91.28.85.80                |
| Fax : +33  4.91.63.65.10                |
| olivier@piimsdm9.univ-mrs.fr           / 
|_______________________________________/



From chemistry-request@www.ccl.net  Tue Sep 22 14:23:20 1998
Received: from post.mail.demon.net (post-11.mail.demon.net [194.217.242.40])
        by www.ccl.net (8.8.3/8.8.6/OSC/CCL 1.0) with ESMTP id OAA21951
        Tue, 22 Sep 1998 14:23:19 -0400 (EDT)
Received: from [158.152.83.101] (helo=chmqst.demon.co.uk)
	by post.mail.demon.net with smtp (Exim 2.03 #1)
	id 0zLX5C-0005AF-00
	for chemistry@www.ccl.net; Tue, 22 Sep 1998 18:22:39 +0000
From: David Livingstone <davel@chmqst.demon.co.uk>
Organization: ChemQuest
To: chemistry@www.ccl.net
Date: Tue, 22 Sep 1998 10:11:04 +0100
Subject: Re: CCL:Prospectives in Drug Design
Reply-to: davel@chmqst.demon.co.uk
Priority: normal
X-mailer: Pegasus Mail for Win32 (v3.01b)
Message-Id: <E0zLX5C-0005AF-00@post.mail.demon.net>



Hi,


It is actually called "Perspectives in Drug...."


> has anybody heard about the series "Prospectives in Drug Discovery and
> Design" published in Kluver/Escom? Where are those paperbacks
> available?


The usual places, like libraries.


> How many volumes do exist and what are their titles?


The latest volume I have seen is 14.  I should ask Kluwer or a library for the 
titles.


	Dave.

------------------------------------------------------------------
D.J. Livingstone                ChemQuest
                       Cheyney House, 19-21 Cheyney St.,
                       Steeple Morden. Herts UK SG8 0LP 

Phone & Fax: +44 (0)1763 852569 
e-mail davel@chmqst.demon.co.uk   http://www.chmqst.demon.co.uk
------------------------------------------------------------------


From chemistry-request@www.ccl.net  Tue Sep 22 14:28:39 1998
Received: from mailbox2.ucsd.edu (mailbox2.ucsd.edu [132.239.1.54])
        by www.ccl.net (8.8.3/8.8.6/OSC/CCL 1.0) with ESMTP id OAA21986
        Tue, 22 Sep 1998 14:28:38 -0400 (EDT)
Received: from chemcca10.ucsd.edu (chemcca10.ucsd.edu [132.239.68.250]) by mailbox2.ucsd.edu (8.8.8AS/8.6.9) with ESMTP id LAA24953; Tue, 22 Sep 1998 11:28:40 -0700 (PDT)
Received: from chemcca10 (localhost [127.0.0.1]) by chemcca10.ucsd.edu (980427.SGI.8.8.8/970903.SGI.AUTOCF) via SMTP id LAA19858; Tue, 22 Sep 1998 11:28:37 -0700 (PDT)
Sender: wweber@chemcca10.ucsd.edu
Message-ID: <3607EC55.794B@chemcca10.ucsd.edu>
Date: Tue, 22 Sep 1998 11:28:37 -0700
From: Wolfgang Weber <wweber@chemcca10.ucsd.edu>
Organization: University of California at San Diego
X-Mailer: Mozilla 3.0Gold (X11; I; IRIX 6.2 IP22)
To: "Márcio Cyrillo" <cyrillo@ifi.unicamp.br>
CC: CHEMISTRY@www.ccl.net
Subject: Re: CCL:Restraining dihedrals using HyperChem
References: <36069DEB.B4A65628@ifi.unicamp.br>


Hi Marcio,

technically speaking it is no problem to add any MM type
potential to a semiempirical Hamiltonian for restraint
purposes. One just adds the corresponding forces to the
QM forces. In fact, this is done even in "old and good
MOPAC", for PM3. PM3 predicts the amide bond to be non-
planar, in variance with experiment. Jimmy Stewart has
therefore added a restraint potential to the related
dihedral to keep the amide system planar. This is the
default which can be switched off.

However, I do not know what HyperChem is about and what
it does.

Wolfgang





Márcio Cyrillo wrote:
> 
> Dear HyperChemists,
> 
> I would like to ask you something that I think is very strange about
> HyperChem Geometry Optimization (GO) calculations. Actually I had
> already asked this before but the latter support man from HyperCube (Dr.
> Stravrev) did not want or did not know how to answer to my question. I
> think its about time to clear this issue! I hope someone can help me.
> The problem is: we read in HyperChem manual that for GO optimizations we
> can restraint a variable (bond length, angle or dihedral) using a
> restraing constant that adds a force field to the hamiltonian of the
> system so that a potential like that of a spring can "hold" the variable
> to a specific supplied value. This "Hook" constant, default value equals
> 60,  is set up depending on the problem, but in the manual they tell us
> that it cannot be as big as we want because we would then add a
> nonlinear term that would perturbate the original hamiltonian producing
> artificial results.
> I have the following questions:
> - For molecular mechanics I understand this procedure of adding a
> quadratic potential to the hamiltonian to restrain a variable, but it
> seems to me as being meaningless to apply the same procedure to a
> semi-empirical hamiltonian. Am I wrong?
> - In mopac we can easily accomplish the restraint of a variable -
> changing a digit from 1 to 0 in the z-matrix scheme. Why did not
> HyperChem use the same algorithm? With MOPAC it works fine, which is
> pretty different in HyperChem where it almost impossible to, in fact,
> restrain the variable to the desired value. Everyone that has used my
> program HyperSpin (www.ifi.unicamp.br) before, knows what I mean.
> Talking about HyperSpin, I am going to release a new version soon but I
> am also working on a interface that will do quite the same work but
> using old and good MOPAC6.
> I am looking forward to hearing from you soon, best regards,
> Marcio.
> --
> Marcio Cyrillo - http://www.ifi.unicamp.br/~cyrillo
> email: cyrillo@ifi.unicamp.br or mcyrillo@yahoo.com
> ICQ: 14059279
> Graduate Student
> State University of Campinas (UNICAMP), SP, Brazil
> Applied Physics Department - DFA/IFGW
> room 51, phone +55 19 788 5364, fax +55 19 788 5376
> 
> ---
> Administrivia: This message is automatically appended by the mail exploder:
> CHEMISTRY@www.ccl.net: Everybody | CHEMISTRY-REQUEST@www.ccl.net: Coordinator
> MAILSERV@www.ccl.net: HELP CHEMISTRY or HELP SEARCH | Gopher: www.ccl.net 73
> Anon. ftp: www.ccl.net   | CHEMISTRY-SEARCH@www.ccl.net -- archive search
>              Web: http://www.ccl.net/chemistry.html
> ---

-- 
Dr. Wolfgang Weber
Dept. of Chemistry and Biochemistry
University of California, San Diego
La Jolla, CA 92093-0365
Phone (619) 534 3038 Fax (619) 534 7042
http://chemcca10.ucsd.edu/~wweber


From chemistry-request@www.ccl.net  Tue Sep 22 17:55:53 1998
Received: from mail2.one.net (mail2.one.net [206.112.192.100])
        by www.ccl.net (8.8.3/8.8.6/OSC/CCL 1.0) with ESMTP id RAA24103
        Tue, 22 Sep 1998 17:55:52 -0400 (EDT)
Received: from port-47-27.access.one.net ([206.112.203.31] EHLO one.net ident: IDENT-NOT-QUERIED [port 48137]) by mail2.one.net with ESMTP id <16291-22734>; Tue, 22 Sep 1998 17:55:45 -0400
Message-ID: <36081C58.D6CAAAFE@one.net>
Date: 	Tue, 22 Sep 1998 17:53:28 -0400
From: Ray Crawford <iguana@one.net>
X-Mailer: Mozilla 4.04 [en] (Win95; I)
To: CHEMISTRY@www.ccl.net
Subject: Help finding proteins in the PDB...
References: <36069DEB.B4A65628@ifi.unicamp.br>



Howdy all!!!

 I had a question about the contents of the PDB.  I’m currently doing an
examination of a macromolecular docking program and I am looking for various
ligand/protein complex test cases.  Ideally I would like to find two proteins
which have 5-10 experimentally determined structures, each with different ligands
(ie Dihydrofolate Reductase with 5-10 different experimentally determined ligands
in the active site).  The two examples I was thinking about were:

1.) a protein with an active-site-surface cleft such as cyclophilin A.
2.) a protein with a partially or completely enclosed pocket like the retonioc
acid binding protein RXRg.

So far, I have looked at two examples -- ~10 experimentally determined HIV
protease complexes (which have not been deposited in the PDB) and 4 cyclophilin A
complexes.  The problem with the HIV protease case is that the active site is too
darn symmetrical and I think that it is not a fair test of the program’s
“docking” ability – there are too many “good” orientations for the ligand (i.e.,
the program finds plausible binding modes but they are all WAY off from the
experimental binding mode).  CypA, on the other hand,  is a perfect example of a
cleft binding site but there are only 4 structures of small, drug-like molecules
experimentally determined in the PDB (and they are all dipeptides which, I might
add, the program nails right on…) – I think that this example is too easy.

 So, my question is two-fold.  Do you all think I am neglecting any important
“binding modes” by limiting my examination to surface clefts and enclosed
pockets, and does any one know of any proteins in the PDB (or coordinate sets you
would be willing to share…) that fit these criteria?

 Thanks,
  Ray Crawford
  Research Associate
  The Procter & Gamble Co.




